Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,750.00p
   
  • Change Today:
      24.00p
  • 52 Week High: 2,774.00
  • 52 Week Low: 1,637.00
  • Currency: UK Pounds
  • Shares Issued: 66.03m
  • Volume: 134,880
  • Market Cap: £1,155.55m
  • RiskGrade: 128

Genus sees FY earnings in line with expectations

By Frank Prenesti

Date: Wednesday 23 Nov 2022

LONDON (ShareCast) - (Sharecast News) - Animal genetic company Genus said it expected annual pre-tax profits to be in line with expectations with performance weighted to the second half.
In a statement ahead of its annual general meeting, Genus said the benefit of favourable exchange rates was expected to be largely offset by higher interest costs in the year.

"While market conditions in bovine have been challenging, porcine has performed well in the first four months. Pig prices in China remained at a profitable level for producers, which we anticipate will lead to improved demand for porcine genetics in the second half of financial year 2023," the company said.

"Although Covid restrictions in China continue to be a headwind to a recovery in demand, PIC China remains well positioned to capture the growth opportunity as it develops."

"At current prices, producers are profitable, and we anticipate this should lead to improved confidence for producers to replace and rebuild sow herds over time. However, Covid restrictions in China present continuing challenges for businesses and consumers, impacting demand for pork."

Reporting by Frank Prenesti for Sharecast.com

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 1,750.00p
Change Today 24.00p
% Change 1.39 %
52 Week High 2,774.00
52 Week Low 1,637.00
Volume 134,880
Shares Issued 66.03m
Market Cap £1,155.55m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
95.64% below the market average95.64% below the market average95.64% below the market average95.64% below the market average95.64% below the market average
96.23% below the sector average96.23% below the sector average96.23% below the sector average96.23% below the sector average96.23% below the sector average
Price Trend
62.06% below the market average62.06% below the market average62.06% below the market average62.06% below the market average62.06% below the market average
26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average
Income
85.7% below the market average85.7% below the market average85.7% below the market average85.7% below the market average85.7% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
69.53% below the market average69.53% below the market average69.53% below the market average69.53% below the market average69.53% below the market average
56.76% below the sector average56.76% below the sector average56.76% below the sector average56.76% below the sector average56.76% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 29-Feb-24 09-Nov-23
Paid 28-Mar-24 08-Dec-23
Amount 10.30p 21.70p

Trades for 23-Apr-2024

Time Volume / Share Price
16:35 46,954 @ 1,750.00p
16:35 300 @ 1,750.00p
16:35 112 @ 1,750.00p
16:35 319 @ 1,750.00p
16:35 738 @ 1,750.00p

Genus Key Personnel

CFO Alison Henriksen
CEO Jorgen Kokke

Top of Page